A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04800562 |
Recruitment Status :
Active, not recruiting
First Posted : March 16, 2021
Last Update Posted : February 27, 2023
|
Sponsor:
Processa Pharmaceuticals
Information provided by (Responsible Party):
Processa Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | March 31, 2023 |
Estimated Study Completion Date : | December 1, 2023 |